|
|
|
40
|
0112CH
|
ZINNAT 50MG/ML SUSP (GSK/COL) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
70ML
|
C
|
25.66
|
0.26
|
SUSPENSION
|
0
|
ML
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
Package Size Change
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-21
|
|
|
|
41
|
0112CK
|
CEFADROXIL 50MG/ML SUSP (MBL)
|
CEFADROXIL
|
CEFADROXIL
|
60ML
|
A
|
7.96
|
0.1327
|
ML
|
120
|
BOTT
|
MBL
|
MEDICAMEN BIOTECH LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
FIRST GEN CEPHALOSPORINS
|
|
|
|
|
41
|
0112CM
|
ZINNAT 25MG/ML SUSP (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
100ML
|
BQ
|
25.66
|
0.2566
|
ML
|
21
|
BOTT
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SECOND GEN CEPHALOSPORINS
|
2023-08-10
|
|
|
|
42
|
0112CM
|
ZINNAT 25MG/ML SUSP (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
100ML
|
BH
|
38.19
|
0.38
|
ML
|
21
|
BOTT
|
BCH
|
SANDOZ
|
COL
|
AVENTA BARBADOS
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2026-04-01
|
|
|
ORAL
|
0
|
SECOND GEN CEPHALOSPORINS
|
|
|
|
|
41
|
0112CN
|
ZINNAT 50MG/ML SUSP (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
100ML
|
BQ
|
22.67
|
0.2267
|
ML
|
60
|
BOTT
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SECOND GEN CEPHALOSPORINS
|
2023-08-10
|
|
|
|
42
|
0112CN
|
ZINNAT 50MG/ML SUSP (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
70ML
|
BH
|
48.41
|
0.69
|
ML
|
60
|
BOTT
|
BCH
|
SANDOZ
|
COL
|
AVENTA BARBADOS
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2026-04-01
|
|
|
ORAL
|
0
|
SECOND GEN CEPHALOSPORINS
|
|
|
|
|
40
|
0112ZG
|
ZINNAT 25MG/ML SUSP (GSK/COL) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
100ML
|
C
|
28.11
|
0.28
|
SUSPENSION
|
0
|
ML
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0112ZG
|
ZINNAT 25MG/ML SUSP (GSK) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
100ML
|
BQ
|
25.66
|
0.2566
|
ML
|
21
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SECOND GEN CEPHALOSPORINS
|
|
|
|
|
40
|
01133
|
CEFAZOLIN 1G IV/IM INJ (RTM/PHA)
|
CEFAZOLIN
|
CEFAZOLIN
|
1G VIAL
|
B
|
3.89
|
3.89
|
INJECTION
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
01133
|
CEFAZOLIN 1G IV/IM INJ (RTM) (BQ)
|
CEFAZOLIN
|
CEFAZOLIN
|
1G VIAL
|
BQ
|
3.97
|
3.9688
|
VIAL
|
10
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
FIRST GEN CEPHALOSPORINS
|
|
|
|
|
40
|
0113AG
|
CEFAZOLIN 1G IV/IM INJ (KWA/ATB)
|
CEFAZOLIN
|
CEFAZOLIN
|
1G VIAL
|
B
|
4.02
|
4.02
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2022-04-01
|
2022-09-30
|
|
IV/IM
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-30
|
|
|
|
42
|
0113AK
|
CEFAZOLIN 1G INJ (BAX)
|
CEFAZOLIN
|
CEFAZOLIN
|
10ML VIAL
|
BQ
|
2.75
|
2.75
|
VIAL
|
0
|
VIAL
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2026-04-01
|
|
|
IV
|
0
|
FIRST GEN CEPHALOSPORINS
|
|
|
|
|
41
|
0113BA
|
CEFAZOL 1G INJ (INC) (BQ)
|
CEFAZOLIN
|
CEFAZOL
|
15ML VIAL
|
BQ
|
14.19
|
14.1897
|
VIAL
|
0
|
VIAL
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
FIRST GEN CEPHALOSPORINS
|
|
|
|
|
41
|
0113G
|
ALCOVERA 1G INJ (UNI) CEFAZOLIN (BQ)
|
CEFAZOLIN
|
ALCOVERA
|
1G VIAL
|
BQ
|
4.46
|
4.4581
|
VIAL
|
0
|
VIAL
|
UNI
|
UNIQUE PHARMACEUTICAL LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
40
|
0114BP
|
ALTACEF 250MG TAB (GLP/ATB) CEFUROXIME
|
CEFUROXIME
|
ALTACEF
|
10'S
|
BQ
|
4.08
|
0.41
|
TABLET
|
0
|
TAB
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
Change Local Agent
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
2022-03-22
|
|
|
|
40
|
0114BT
|
ZINNAT 250MG TAB (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINNAT 250MG TAB
|
50'S
|
C
|
$97.23
|
1.94
|
TABLET
|
|
TAB
|
BCH
|
SANDOZ USA
|
COL
|
COLLINS LIMITED
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
0000-00-00
|
0000-00-00
|
CONTRACT AWARDED CAT C
|
ORAL
|
|
ANTI-INFECTIVE AGENTS
|
0000-00-00
|
|
|
|
41
|
0114BT
|
ZINNAT 250MG TAB (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
50'S
|
BQ
|
32.46
|
0.6492
|
TAB
|
28
|
BOX
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SECOND GEN CEPHALOSPORINS
|
2023-08-10
|
|
|
|
42
|
0114BT
|
ZINNAT 250MG TAB (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
50'S
|
C
|
64.91
|
1.30
|
TAB
|
28
|
BLIS
|
BCH
|
SANDOZ
|
COL
|
AVENTA BARBADOS
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2026-04-01
|
|
|
ORAL
|
0
|
SECOND GEN CEPHALOSPORINS
|
|
|
|
|
42
|
0114BV
|
XORICEF 250MG TAB (JLP) CEFUROXIME
|
CEFUROXIME
|
XORICEF
|
10X10
|
BQ
|
39.96
|
0.40
|
TAB
|
28
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2026-04-01
|
|
|
ORAL
|
0
|
SECOND GEN CEPHALOSPORINS
|
|
|
|
|
40
|
0114L
|
ZINNAT 250MG TAB (GSK/COL) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
50'S
|
C
|
97.07
|
1.94
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|